Evidence map›Paper›PMID 35511492›Full record

ArticleClinical and experimental immunology2022

Increased radiosensitivity and impaired DNA repair in patients with STAT3-LOF and ZNF341 deficiency, potentially contributing to malignant transformations.

Sukru Cekic, Huzeyfe Huriyet, Melika Hortoglu, Nurhan Kasap, Ahmet Ozen, Elif Karakoc-Aydiner, Ayse Metin, Gokhan Ocakoglu, Candan Demiroz Abakay, Sehime G Temel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Understanding and Managing Hyper IgE Syndromes.ImmunoTargets and therapy · 2025
    Review
  3. Article
  4. Liquid-liquid phase separation-related features ofJournal of gastrointestinal oncology · 2024
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sukru CekicDivision of Pediatric Immunology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.ORCID 0000-0002-9574-1842
Huzeyfe HuriyetCell Culture and Genetic Toxicology Laboratory, Department of Biology, Faculty of Sciences and Arts, Bursa Uludag University, Bursa, Turkey.
Melika HortogluCell Culture and Genetic Toxicology Laboratory, Department of Biology, Faculty of Sciences and Arts, Bursa Uludag University, Bursa, Turkey.
Nurhan KasapDivision of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
Ahmet OzenDivision of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
Elif Karakoc-AydinerDivision of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
Ayse MetinDivision of Pediatric Allergy and Immunology, University of Health Sciences/Ankara City Hospital/Children's Hospital, Ankara, Turkey.
Gokhan OcakogluDepartment of Biostatistics, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Candan Demiroz AbakayDepartment of Radiation Oncology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Sehime G TemelDepartment of Medical Genetics, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Sebnem Ozemri SagDepartment of Medical Genetics, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Safa BarisDivision of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
Tolga CavasCell Culture and Genetic Toxicology Laboratory, Department of Biology, Faculty of Sciences and Arts, Bursa Uludag University, Bursa, Turkey.
Sara Sebnem KilicDivision of Pediatric Immunology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Bursa Uludağ Üni̇versi̇tesi̇ · TRMarmara University · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STAT3 plays an important role in various complex and sometimes contradictory pathways such as proliferation, differentiation, migration, inflammation, and apoptosis. The transcriptional activity of the STAT3 gene is controlled by a transcription factor called ZNF341. There is insufficient data on radiation sensitivity and post-radiation DNA repair in STAT3- loss-of-function (LOF) patients. We aimed to investigate the radiosensitivity in patients with STAT3-LOF and ZNF341 deficiency. Twelve patients with STAT3-LOF and four ZNF341-deficiency patients were recruited from three clinical immunology centers in Turkey and evaluated for radiosensitivity by the Comet assay, comparing to 14 age- and sex-matched healthy controls. The tail length (TL) (μm), percentage of DNA in the tail (TDNA%), and olive tail moment (OTM) (arbitrary units) were evaluated at the same time for baseline (spontaneous), initial (immediately after 2 Gy irradiation), and recovery (2 h after irradiation) periods by using a computerized image-analysis system, estimating DNA damage. Except for a patient with ZNF341 deficiency who developed nasal cell primitive neuroendocrine tumor and papillary thyroid cancer during the follow-up, there was no cancer in both groups. During the recovery period of irradiation, TL, TDNA%, and OTM values of healthy controls decreased rapidly toward the baseline, while these values of patients with STAT3-LOF and ZNF341 deficiency continued to increase, implying impaired DNA repair mechanisms. Increased radiosensitivity and impaired DNA repair were demonstrated in patients diagnosed with STAT3-LOF and ZNF341 deficiency, potentially explaining the susceptibility to malignant transformation.

Indexed as

DNA RepairRadiation ToleranceSTAT3 Transcription FactorTranscription FactorsComet AssayDNA DamageGene Expression RegulationHumansLoss of Function MutationSTAT3 protein, humanSTAT3 Transcription FactorTranscription FactorsZNF341 protein, humanComet assayDNA repairradiosensitivitySTAT3-LOFZNF-341 deficiency

Identifiers

PMID35511492
PMCPMC9307231
OpenAlexW4229020948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.